Why are we still in need for novel anti-obesity medications? - Novikoff, Aaron; Grandl, Gerald; Liu, Xue; D. Müller, Timo (The Lancet regional health. Europe, 2024)
Keywords: Anti-obesity medication (AOM); Diabetes; GIP; GLP-1; Internal Medicine; Obesity; Public Health; Viewpoint; Obesity; GLP-1; Diabetes; Anti-obesity medication (AOM); GIP